Enzyme Integrates with Morpho
Enzyme has now integrated with Morpho, a transformative protocol built on top of renowned lending pools like Compound and Aave. With this collaboration, Enzyme’s asset managers can now use Morpho to enhance yields while preserving the same liquidity, liquidation guarantees, and risk parameters associated with the underlying protocol.
The world of DeFi is an ecosystem of infinite potential and diverse opportunities. Yet, unlocking this potential and capitalising on these opportunities can be a complex task. This is where the integration of Morpho and Enzyme comes into play, combining the strengths of two powerful DeFi platforms to deliver an unrivalled asset management experience.
As an asset manager, your priority is to maximise returns while minimising risks. Efficiency, flexibility, simplicity, and safety become the cornerstones of your investment strategy. The fusion of Morpho’s innovative peer-to-peer lending mechanism with Enzyme’s robust suite of asset management tools offers exactly that.
So, what can asset managers expect when they use Morpho on Enzyme? A wealth of benefits that revolve around four core principles:
Improved rates: Positions on Morpho are more capital efficient thanks to seamless peer-to-peer matching. This leads to better APYs for asset managers and increases overall returns.
Attractive Risk-Adjusted Returns: Morpho improves rates without changing the underlying risk. As an asset manager, you always receive a rate equal to or better than the underlying pool, while maintaining the same risk parameters and liquidation guarantees.
Intuitive Integration: With Enzyme’s robust front-to-back execution and order management system, users can add Morpho positions to their portfolio in a few clicks.
DAO Treasury Management: Enzyme’s programmable risk management and trader delegation tools means DAOs can outsource the operations of their treasury to one or more asset managers and can add Morpho into existing strategies while maintaining their risk controls.
As the DeFi space continues to evolve, the team at Enzyme is committed to providing asset managers with the tools they need to maximise their yield opportunities. Enzyme’s integration with Morpho is a testament to this commitment, enabling access to optimised rates for lenders. Embrace this new era of asset management with Enzyme and Morpho, where safety and efficiency meets innovation.
With Enzyme’s v4 Sulu, it’s never been easier for managers to create custom on-chain asset management strategies, access dozens of DeFi d’Apps and trade 250+ digital assets in one simple, trustless, and efficient platform.
Morpho is an innovative peer-to-peer layer that significantly enhances the capital efficiency of leading lending pools such as Compound and Aave. It accomplishes this by implementing a unique mechanism that seamlessly matches lenders and borrowers on a peer-to-peer basis. As a result, Morpho can offer improved rates, thus optimising the lending experience while maintaining the same liquidity, liquidation guarantees, and risk parameters of the underlying protocol.
At its core, Morpho operates as a lending pool optimizer. It ensures that users interact with Morpho-Aave or Morpho-Compound the same way they would with the native Aave or Compound protocols. This means users still have access to billions of dollars ready to be borrowed or withdrawn, while also enjoying the same collateral factors, oracles, close factors, etc. The fundamental difference lies in the enhanced rates that Morpho can offer to both borrowers and lenders.